common.study.topics.clinical

New Serum Markers to Monitor Anti-Cancer Therapy Response

common.study.values.description

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be useful for confirming the diagnosis or for selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Procedure - blood draw

participant.views.study.view.additional

participant.views.study.view.scientific-title

Development of Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

common.study.values.clinical-trial-id

NCT00349830

participant.views.study.view.id

PdyP7b